A Study to Assess the Relative Bioavailability of Four New Formulations of GSK1605786 in Healthy Subjects A Study to Assess the Relative Bioavailability of Four New Formulations of GSK1605786 in Healthy Sub ...
A Single Dose, Randomized, Five-Period Crossover Study to Assess the Relative Bioavailability of Four New Formulations of the CCR9 Receptor Antagonist GSK1605786A (CCX282) in Healthy Male and Female Subjects A Single Dose, Randomized, Five-Period Crossover Study to Assess the Relative Bioavailability of Fou ...